These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28393626)

  • 21. Insight into the interaction mechanism of human SGLT2 with its inhibitors: 3D-QSAR studies, homology modeling, and molecular docking and molecular dynamics simulations.
    Dong L; Feng R; Bi J; Shen S; Lu H; Zhang J
    J Mol Model; 2018 Mar; 24(4):86. PubMed ID: 29511885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Virtual Screening of Novel and Selective Inhibitors of Protein Tyrosine Phosphatase 1B over T-Cell Protein Tyrosine Phosphatase Using a Bidentate Inhibition Strategy.
    Chen X; Gan Q; Feng C; Liu X; Zhang Q
    J Chem Inf Model; 2018 Apr; 58(4):837-847. PubMed ID: 29608303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A mechanistic approach to explore novel HDAC1 inhibitor using pharmacophore modeling, 3D- QSAR analysis, molecular docking, density functional and molecular dynamics simulation study.
    Choubey SK; Jeyaraman J
    J Mol Graph Model; 2016 Nov; 70():54-69. PubMed ID: 27668885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Designing of potential inhibitors against Staphylococcus aureus sortase A: Combined analogue and structure based approach with in vitro validation.
    Raj KK; Ganesh Kumar V; Leela Madhuri C; Mathi P; Durga Lakshmi R; Ravi M; Sri Ramudu B; Venkata Rao SV; Ramachandran D
    J Mol Graph Model; 2015 Jul; 60():89-97. PubMed ID: 26119984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural Investigation of Vinca Domain Tubulin Binders by Pharmacophore, Atom based QSAR, Docking and Molecular Dynamics Simulations.
    Athar M; Lone MY; Khedkar VM; Radadiya A; Shah A; Jha PC
    Comb Chem High Throughput Screen; 2017; 20(8):682-695. PubMed ID: 28486912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of promising FtsZ inhibitors by E-pharmacophore, 3D-QSAR, molecular docking study, and molecular dynamics simulation.
    Qiu Y; Zhou L; Hu Y; Bao Y
    J Recept Signal Transduct Res; 2019 Apr; 39(2):154-166. PubMed ID: 31355691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular dynamics studies on the interactions of PTP1B with inhibitors: from the first phosphate-binding site to the second one.
    Wang JF; Gong K; Wei DQ; Li YX; Chou KC
    Protein Eng Des Sel; 2009 Jun; 22(6):349-55. PubMed ID: 19380334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
    Islam MA; Pillay TS
    J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding and discerning interactions of PTP1B allosteric inhibitors: novel insights from molecular dynamics simulations.
    Shinde RN; Sobhia ME
    J Mol Graph Model; 2013 Sep; 45():98-110. PubMed ID: 24012873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of selective binding of inhibitors to PTP1B and TCPTP by accelerated molecular dynamics simulations.
    Chen X; Gan Q; Feng C; Liu X; Zhang Q
    J Biomol Struct Dyn; 2019 Sep; 37(14):3697-3706. PubMed ID: 30238851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An investigation on 4-thiazolidinone derivatives as dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B, in the search for potential agents for the treatment of type 2 diabetes mellitus and its complications.
    Maccari R; Del Corso A; Paoli P; Adornato I; Lori G; Balestri F; Cappiello M; Naß A; Wolber G; Ottanà R
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3712-3720. PubMed ID: 30342956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery and evaluation of the hybrid of bromophenol and saccharide as potent and selective protein tyrosine phosphatase 1B inhibitors.
    Zhang R; Yu R; Xu Q; Li X; Luo J; Jiang B; Wang L; Guo S; Wu N; Shi D
    Eur J Med Chem; 2017 Jul; 134():24-33. PubMed ID: 28395151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective binding modes and allosteric inhibitory effects of lupane triterpenes on protein tyrosine phosphatase 1B.
    Jin T; Yu H; Huang XF
    Sci Rep; 2016 Feb; 6():20766. PubMed ID: 26865097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening and identification of potential PTP1B allosteric inhibitors using in silico and in vitro approaches.
    Shinde RN; Kumar GS; Eqbal S; Sobhia ME
    PLoS One; 2018; 13(6):e0199020. PubMed ID: 29912965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ligand-based and e-pharmacophore modeling, 3D-QSAR and hierarchical virtual screening to identify dual inhibitors of spleen tyrosine kinase (Syk) and janus kinase 3 (JAK3).
    Kaur M; Silakari O
    J Biomol Struct Dyn; 2017 Nov; 35(14):3043-3060. PubMed ID: 27678281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Docking analysis targeted to the whole enzyme: an application to the prediction of inhibition of PTP1B by thiomorpholine and thiazolyl derivatives.
    Ganou CA; Eleftheriou PT; Theodosis-Nobelos P; Fesatidou M; Geronikaki AA; Lialiaris T; Rekka EA
    SAR QSAR Environ Res; 2018 Feb; 29(2):133-149. PubMed ID: 29347844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of novel, high potent, ABC type PTP1B inhibitors with TCPTP selectivity and cellular activity.
    Liu P; Du Y; Song L; Shen J; Li Q
    Eur J Med Chem; 2016 Aug; 118():27-33. PubMed ID: 27123900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of Bisindole as a Novel Scaffold for Protein Tyrosine Phosphatase 1B Inhibitors.
    Jing C; Li Z; Jia K; Chen C; Liu X; Wang B; Hu W; Li J; Zhu T; Dong S
    Arch Pharm (Weinheim); 2017 Jan; 350(1):. PubMed ID: 28029177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The discovery of a novel and selective inhibitor of PTP1B over TCPTP: 3D QSAR pharmacophore modeling, virtual screening, synthesis, and biological evaluation.
    Ma Y; Jin YY; Wang YL; Wang RL; Lu XH; Kong DX; Xu WR
    Chem Biol Drug Des; 2014 Jun; 83(6):697-709. PubMed ID: 24418013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacophore modeling, 3D-QSAR, and in silico ADME prediction of N-pyridyl and pyrimidine benzamides as potent antiepileptic agents.
    Malik R; Mehta P; Srivastava S; Choudhary BS; Sharma M
    J Recept Signal Transduct Res; 2017 Jun; 37(3):259-266. PubMed ID: 27607834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.